Tokyo, Dec. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060098) titled 'Effectiveness and safety of home-visiting chemotherapy for advanced cancer patients with difficulty receiving hospital-based chemotherapy' on Dec. 16.
Study Type:
Observational
Primary Sponsor:
Institute - Tendai Medical Corporation, Tsuruta Clinic
Condition:
Condition - Unresectable advanced cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To retrospectively evaluate the effectiveness and safety of home-visiting chemotherapy provided as part of routine clinical practice in patients with unresectable advanced cancer not considered eligible for hospital-b...